PierianDx, Inc. — Form D
PierianDx, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-12. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-12
- Form: D
- Accession: 0001730902-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Minimum investment: $60K
- Investors: 4
- Date of first sale: 2018-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-305344
Issuer
- Name: PierianDx, Inc.
- CIK: 0001730902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 6 Cityplace Drive, ST. LOUIS, MO, 63141
- Phone: 314-628-0035
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| REID ROBISON | Director | TORONTO, A6 |
| KERRY PROPPER | Director | New York, NY |
| Charles Boorady | Director | Brentwood, TN |
| Brian Carey | Director | New York, NY |
| Chris Callahan | Executive Officer | New York, NY |
| Mark McDonough | Director | Irvine, CA |
| Mark McDonough | Executive Officer | Irvine, CA |
| James Starr | Executive Officer | Los Angeles, CA |
| Barnard Buscemi | Director | St. Louis, MO |
| Rakesh Nagarajan | Director | St. Louis, MO |
| Rakesh Nagarajan | Executive Officer | St. Louis, MO |
| Joseph Boorady | Director | St. Louis, MO |
| Frederick Hessler | Director | St. Louis, MO |
| Bryan Carey | Director | St. Louis, MO |
| Michael Sanderson | Director | St. Louis, MO |
| Michael Sanderson | Executive Officer | St. Louis, MO |
| Peter Jobse | Director | St. Louis, MO |
Other filings by this issuer (2)
More